Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
SHIFTBIO
Abandoned-Failure To Respond Or L…
Show more
Class 5: Biological preparations comprising exosomes for therapeutic applications, namely, biological preparations for treatment of metabolic and fibrotic disorders, immune diseases, cancer, neurological disorders, ophthalmic diseases, and rare disease
Class 42: Biopharmaceutical research and development services related to new drug modalities including exosomes
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 20 Dec 2021Application filedNew Application Entered
- 22 Sep 2022Assigned to an examining attorneyAssigned To Examiner
- 22 Sep 2022Office action issuedNon-Final Action Written
- 6 Apr 2023Application abandoned — no or late responseAbandonment - Failure To Respond Or Late Response
All 10 events
| 2023-04-06 | Abandonment - Failure To Respond Or Late Response |
| 2023-04-06 | Abandonment Notice Mailed - Failure To Respond |
| 2023-04-06 | Abandonment Notice Mailed - Failure To Respond |
| 2022-09-22 | Assigned To Examiner |
| 2022-09-22 | Non-Final Action Written |
| 2022-09-22 | Non-Final Action E-Mailed |
| 2022-09-22 | Notification Of Non-Final Action E-Mailed |
| 2021-12-22 | Notice Of Design Search Code E-Mailed |
| 2021-12-21 | New Application Office Supplied Data Entered |
| 2021-12-20 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Biological preparations comprising exosomes for therapeutic applications, namely, biological preparations for treatment of metabolic and fibrotic disorders, immune diseases, cancer, neurological disorders, ophthalmic diseases, and rare disease
Class 42 Technology & SaaS
Biopharmaceutical research and development services related to new drug modalities including exosomes
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 21 Dec 2021; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.